GO:0006412 translation: Protein Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006412 translation is the biological process in which the sequence of a mature mRNA or circRNA directs the synthesis of a polypeptide chain on the ribosome.
• Translation begins with formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which then binds the small ribosomal subunit and mRNA or circRNA.
• The process is terminated by release of the completed polypeptide chain from the ribosome.
• Translation is a major determinant of gene expression and is tightly regulated in development, immunity, and disease [2,3].
• Dysregulated translation is implicated in cancer, neurodegeneration, and ribosomopathies [4,5].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of translation-related genes [6,7].
Description
GO:0006412 translation is the cellular metabolic process in which a protein is formed using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. This process is mediated by the ribosome and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome. Because translation converts genetic information into functional proteins, it is a central node in gene expression and a frequent target of cellular regulation [2,3]. Researchers study translation to understand how cells control protein abundance, respond to stress, and maintain proteostasis [4,5]. Defects in translation are linked to a broad spectrum of human diseases, including cancer, neurodegeneration, and ribosomopathies [6,7]. Consequently, experimental models that perturb translation-related genes are essential for mechanistic and therapeutic discovery.
translation At A Glance
| GO ID | GO:0006412 |
|---|---|
| GO term | translation |
| Ontology | biological_process |
| Synonym | protein translation |
| Major function | Ribosome-mediated synthesis of a polypeptide chain using a mature mRNA or circRNA template |
| Initiation | Formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, followed by association with the small ribosomal subunit and mRNA or circRNA |
| Termination | Release of the polypeptide chain from the ribosome |
| Template | Mature mRNA or circRNA |
| Cellular machinery | Ribosome |
What Is GO:0006412?
In your own words, GO:0006412 translation is the ribosome-mediated biosynthetic process that reads the nucleotide sequence of a mature mRNA or circRNA and produces a corresponding polypeptide chain. It starts when aminoacylated initiator methionine tRNA, GTP, and initiation factor 2 assemble into a ternary complex that binds the small ribosomal subunit and the mRNA or circRNA. The ribosome then decodes the message and links amino acids into a polypeptide, and the process ends when the completed chain is released from the ribosome.
Why Is translation Important in Cell Biology?
Translation is important because it is the final step in the expression of most protein-coding genes and therefore determines the amount and timing of protein production in cells [2,3]. It enables rapid and reversible control of gene expression, allowing cells to respond to developmental cues, stress, and immune signals [4,5]. Because translation consumes substantial energy and resources, its dysregulation contributes to cancer, neurodegeneration, and inherited ribosomopathies [6,7]. Understanding translation is also critical for interpreting the effects of genetic variants and for designing therapies that target protein synthesis.
• Translation is the process that converts mRNA or circRNA sequence information into polypeptide sequence, making it essential for gene expression.
• It is a major regulatory hub that controls protein abundance post-transcriptionally.
• Translation initiation is a key step for rapid cellular responses to stress and growth signals.
• Dysregulated translation contributes to cancer cell proliferation and survival.
• Defects in translation machinery cause ribosomopathies and neurodevelopmental disorders.
• Neurodegenerative diseases often involve impaired translation and proteostasis.
• Translation is targeted by many antibiotics and therapeutic agents.
• CRISPR models of translation genes help establish causality in disease.
• Ribosome profiling and proteomics are used to measure translation genome-wide.
• Understanding translation informs mRNA vaccine and therapeutic design.
What Happens During translation?
Initiation
In simple terms: Translation starts when the ribosome, initiator tRNA, and mRNA come together.
Initiation begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. This step is rate-limiting and highly regulated, and it determines which mRNAs are translated.
Elongation
In simple terms: The ribosome reads the mRNA and adds amino acids one by one.
During elongation, the ribosome decodes successive codons of the mRNA or circRNA and catalyzes peptide bond formation between amino acids delivered by tRNAs, extending the polypeptide chain. Elongation factors and GTP hydrolysis drive the cycle of tRNA selection and translocation.
Termination and release
In simple terms: The finished protein is cut free from the ribosome.
Translation ends with the release of a polypeptide chain from the ribosome. Release factors recognize stop codons and promote hydrolysis of the peptidyl-tRNA bond, freeing the newly synthesized protein.
Ribosome recycling
In simple terms: The ribosome is taken apart and reused for the next round.
After termination, the ribosomal subunits, mRNA, and tRNA are recycled so that the ribosome can initiate another round of translation. Recycling factors and initiation factors cooperate to maintain efficient protein synthesis.
Co-translational folding and targeting
In simple terms: Proteins begin to fold and are sent to the right place while being made.
As the polypeptide emerges from the ribosome, it can fold and be targeted to cellular destinations, coupling translation to protein quality control. This co-translational process helps prevent aggregation and ensures proper localization.
Key Genes Involved in GO:0006412 translation
The following genes and proteins are central to translation and are frequently studied using CRISPR models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF2S1 | Initiation factor 2 subunit that forms the ternary complex with initiator tRNA and GTP | Target for studying translation initiation and stress responses |
| EIF2B1 | Guanine nucleotide exchange factor for eIF2, required for ternary complex recycling | Mutations cause leukoencephalopathy; model for translation regulation |
| EIF4E | Cap-binding protein that recruits ribosomes to mRNA | Oncogene and target for translation inhibition in cancer |
| EIF4G1 | Scaffold protein linking eIF4E and eIF3 during initiation | Studied in cancer and neurodegeneration |
| RPS6 | Small ribosomal subunit protein; component of the 40S subunit | Marker of mTOR-dependent translation activation |
| RPL11 | Large ribosomal subunit protein; part of 60S subunit | Implicated in ribosomopathies and p53 activation |
| RACK1 | Ribosome-associated scaffold protein | Regulates translation and is linked to cancer |
| EEF1A1 | Elongation factor that delivers aminoacyl-tRNA to the ribosome | Overexpressed in cancers; target for study |
| EEF2 | Elongation factor mediating translocation | Regulated by phosphorylation; involved in translation control |
| ETF1 | Release factor that recognizes stop codons | Model for termination and ribosome recycling |
| GSPT1 | Release factor involved in termination | Target for degradation in cancer therapy |
| EIF4EBP1 | Repressor of eIF4E; inhibited by mTOR | Key node in mTOR-regulated translation |
| RPS6KB1 | Kinase activated by mTOR that promotes translation | Biomarker and target in cancer |
| EIF3A | Subunit of initiation factor 3 complex | Studied in translation initiation and cancer |
| PABPC1 | Poly(A)-binding protein that enhances translation | Model for mRNA stability and translation |
| EIF2AK1 | Heme-regulated inhibitor kinase that phosphorylates eIF2α | Studied in stress responses and erythropoiesis |
| EIF2AK4 | GCN2 kinase that phosphorylates eIF2α under amino acid stress | Target for integrated stress response studies |
How Is translation Regulated?
Translation is regulated at multiple levels. The mTOR pathway controls initiation by phosphorylating eIF4E-binding proteins and ribosomal protein S6 kinases, thereby promoting cap-dependent translation [2,6]. The integrated stress response (ISR) kinases phosphorylate eIF2α to reduce global translation while favoring translation of stress-responsive mRNAs. Additional regulation occurs through microRNAs, RNA-binding proteins, and post-translational modifications of ribosomal proteins and elongation factors [4,5]. These mechanisms allow cells to rapidly adjust protein synthesis to nutrient availability, stress, and growth signals.
translation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF2B1 | Leukoencephalopathy with vanishing white matter | Knock-in of patient mutations in cell lines |
| RPL11 | Diamond-Blackfan anemia and ribosomopathy | Knockout in hematopoietic cells |
| EIF4E | Cancer proliferation and survival | Overexpression in cancer cell lines |
| EIF2AK4 | Integrated stress response and amino acid stress | Point mutation of kinase domain |
| GSPT1 | Cancer therapy target | Knockout or degron knock-in |
Cancer
Many cancers exhibit increased translation initiation driven by oncogenic signaling, and targeting translation factors such as eIF4E or mTOR effectors can suppress tumor growth [4,6]. Dysregulated translation supports proliferation, survival, and metastasis.
Neurodegeneration
Impaired translation and proteostasis contribute to neurodegenerative diseases, including amyotrophic lateral sclerosis and Alzheimer's disease [5,7]. Mutations in translation-related genes can cause neuronal dysfunction.
Ribosomopathies
Inherited defects in ribosomal proteins or assembly factors cause ribosomopathies such as Diamond-Blackfan anemia and Shwachman-Diamond syndrome [7,8]. These disorders highlight the importance of translation machinery in tissue homeostasis.
Metabolic and stress disorders
Altered translation contributes to metabolic stress responses and is linked to conditions such as diabetes and inflammation [3,6]. The integrated stress response modulates translation to adapt to metabolic challenges.
From translation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an initiation factor reduce global translation? | Knockout cell line |
| Does a disease-associated point mutation alter translation? | Point mutation knock-in |
| Can a tagged ribosomal protein track translation sites? | Tagged knock-in |
| Does overexpression of eIF4E drive oncogenic translation? | Overexpression cell model |
| Which genes regulate translation under stress? | CRISPR library screening |
| How does a translation gene affect proteome output? | Knockout plus proteomics |
How to Study the translation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy on mRNAs | Genome-wide translation efficiency |
| RNA-seq | mRNA abundance | Transcriptome changes after perturbation |
| Proteomics | Protein levels and modifications | Validation of translation output |
| Polysome profiling | Distribution of mRNAs across ribosomes | Initiation and elongation analysis |
| Puromycin labeling | Active translation in cells | Imaging and flow cytometry |
| Luciferase reporter | Cap-dependent translation | Drug and genetic screens |
| CRISPR screening | Gene requirements for translation | Discovery of regulators |
Ribosome profiling (Ribo-seq)
Ribo-seq maps ribosome-protected mRNA fragments to measure translation genome-wide and identify changes in initiation and elongation. It is widely used to study translation regulation and drug effects.
RNA sequencing and transcriptomics
RNA-seq quantifies mRNA levels and can be combined with Ribo-seq to distinguish transcriptional from translational changes. It helps identify pathways affected by translation gene perturbations.
Proteomics
Mass spectrometry-based proteomics measures protein abundance and modifications, providing a direct readout of translation output. It is used to validate CRISPR models of translation genes.
Imaging and reporter assays
Fluorescent reporters and puromycin labeling allow visualization of translation in live cells and tissues. These methods are useful for studying localization and dynamics of translation.
How CRISPR Can Be Used to Study GO:0006412 translation
Knockout
CRISPR knockout of translation genes such as EIF4E or RPL11 can reveal their essential roles in cell viability and protein synthesis [4,7]. Knockout models are used to test whether a gene is required for translation under specific conditions.
Point Mutation
Point mutation knock-in can model disease-associated variants in translation factors, such as EIF2B1 mutations, to study their functional impact. These models help distinguish loss-of-function from gain-of-function effects.
Knock-in
Tagged knock-in of ribosomal proteins or initiation factors enables imaging and biochemical purification of translation complexes. Knock-in of reporters can monitor translation in real time.
Overexpression
Overexpression of translation initiation factors such as EIF4E can drive oncogenic translation and is used to model cancer. Overexpression models help identify downstream effects on the proteome.
How EDITGENE Supports translation Research
Researchers studying translation-related genes often need to determine whether a candidate gene is causally involved in protein synthesis, stress responses, or disease. EDITGENE provides CRISPR-based cell models and screening services to enable these studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for translation research.
Frequently Asked Questions About translation
What is GO:0006412 translation?
GO:0006412 translation is the biological process in which a protein is formed using the sequence of a mature mRNA or circRNA to specify amino acids, mediated by the ribosome.
What genes are involved in translation?
Key genes include EIF2S1, EIF4E, RPS6, RPL11, EEF1A1, and EEF2, among many others [1,2,3].
How does translation begin?
It begins with a ternary complex of aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which binds the small ribosomal subunit and mRNA or circRNA.
How does translation end?
Translation ends with the release of a polypeptide chain from the ribosome.
Why is translation important in cancer?
Dysregulated translation supports cancer cell proliferation and survival, making translation factors therapeutic targets [4,6].
What diseases are linked to translation defects?
Ribosomopathies, neurodegeneration, and metabolic disorders are linked to translation defects [3,5,7].
How is translation regulated?
It is regulated by mTOR signaling, the integrated stress response, and RNA-binding proteins [2,3].
What methods study translation?
Ribo-seq, polysome profiling, proteomics, and imaging are commonly used [2,6,8].
Can CRISPR be used to study translation?
Yes, knockout, point mutation, knock-in, and overexpression models enable causal studies of translation genes [4,7].
What is the role of the ribosome in translation?
The ribosome decodes mRNA or circRNA and catalyzes peptide bond formation to synthesize proteins.
Conclusion
GO:0006412 translation is a fundamental biological process that converts mRNA or circRNA sequence into protein and is essential for cellular function. Its dysregulation underlies many human diseases, and ongoing research continues to reveal regulatory mechanisms and therapeutic opportunities [2,4]. CRISPR-based models and advanced profiling methods are powerful tools for dissecting translation in health and disease [6,7].
References
- 1. Rousseau M et al.. 2021. Translation and Cultural Adaptation of the Ages and Stages Questionnaires (ASQ) Worldwide: A Scoping Review.. J Dev Behav Pediatr 42(6):490-501 PMID: 33990508
- 2. Bello JSD et al.. 2024. Translation and cross-cultural adaptation of the MISSCARE Survey-Ped into Brazilian Portuguese.. Rev Bras Enferm 77(2):e20230060 PMID: 39045973
- 3. Nguyen CM et al.. 2024. Neuropsychological application of the International Test Commission Guidelines for Translation and Adapting of Tests.. J Int Neuropsychol Soc 30(7):621-634 PMID: 39291438
- 4. de Albuquerque SCSO et al.. 2022. Translation and Cross-Cultural Adaptation of the "Early Support Monitoring Protocol".. J Deaf Stud Deaf Educ 28(1):32-39 PMID: 36221903
- 5. Muntlin Å et al.. 2023. Translation and cultural adaptation of the fundamentals of care framework: Are we there yet?. J Adv Nurs 79(3):1107-1118 PMID: 35867344
- 6. Ahmed S et al.. 2024. Translation and linguistic validation of 24 PROMIS item banks into French.. Qual Life Res 33(8):2119-2127 PMID: 38865068
- 7. Golz C et al.. 2024. Translation and Psychometric Testing of the Hägerbäumer Presenteeism Scale in English.. J Occup Rehabil 34(4):863-872 PMID: 38466556
- 8. Santos APO et al.. 2024. Translation and Cross-Cultural Adaptation of the LYMPH-ICF Instrument for Lymphedema into Portuguese/Brazil.. Rev Bras Enferm 77(2):e20230137 PMID: 38896704
